The abstract is read at the publisher; the summary is JClub's.
Impaired glucocorticoid receptor dimerisation in GR dim mice attenuates colon inflammation but produces a biphasic colitis-associated colorectal cancer course with delayed onset and accelerated late growth.
- Why it matters: Progression from ulcerative colitis to colorectal cancer is a major clinical challenge, and how glucocorticoids regulate inflammation and tumourigenesis through GR is not fully defined.
- What they did: GR dim mice were tested in the azoxymethane/dextran sodium sulphate model, with inflammation and tumour outcomes measured alongside transcriptomics, network analysis, tumour organoid experiments, and cross-species comparisons including human CRC survival-linked expression.
- The result: GR dimerisation impairment improved epithelial barrier integrity and reduced pro-inflammatory gene expression, while GR dim tumours showed an inflammatory immune-related signature linked to altered myeloid recruitment/activation and affected both tumour cells and the microenvironment.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.